
-
Syrian leader to meet Macron in first European visit
-
History beckons as cardinals gather to elect new pope
-
China's Xi aims to beef up 'no limits' Putin partnership
-
Hit by Trump cuts, journalists at Dubai-based US channel face uncertain future
-
Roglic gunning for Giro as Pogacar's absence leaves door open
-
Trump's White House creates own media universe
-
Sotheby's postpones historical gems auction after India backlash
-
Taiwan bicycle makers in limbo as US tariff threat looms
-
Tobacco town thrives as China struggles to kick the habit
-
Venezuelan opposition figures 'rescued', now in US: Rubio
-
China eases monetary policy to boost ailing economy
-
Haliburton stunner sinks Cavs as Pacers take 2-0 series lead
-
No rate cuts expected from US Fed facing 'unfavorable' conditions
-
'No one is illegal': Mormon women stage patchwork protest in Washington
-
Indonesia's silvermen beg to make ends meet
-
Toronto festival head says Trump tariffs would hurt film quality
-
Trump talks tough on China, but early focus elsewhere
-
China vows to defend 'justice' in looming trade talks with US
-
Man Utd seek to finish off Athletic Bilbao in chase for Europa glory
-
AP to continue crediting 'Napalm Girl' photo to Nick Ut after probe
-
Colombia moves to join China's Belt and Road
-
Martinez cried 'for two days' after nearly missing Barca triumph with injury
-
US, Chinese officials to hold trade talks in Switzerland
-
Barca 'will be back' after painful Champions League exit to Inter, says Flick
-
US jury awards WhatsApp $168 mn in NSO Group cyberespionage suit
-
India launches strikes on Pakistan, Islamabad vows to 'settle the score'
-
Trump vows 'seamless' experience for 2026 World Cup fans
-
Motown legend Smokey Robinson sued for sexual assault
-
Trump hopes India-Pakistan clashes end 'very quickly'
-
Frattesi shoots Inter into Champions League final after Barcelona epic
-
India launches strikes on Pakistan, Islamabad vows retaliation
-
India launches strikes on Pakistan as Islamabad vows retaliation
-
Alpine shock as F1 team principal Oakes resigns
-
Merz elected German chancellor after surprise setback
-
Gujarat edge Mumbai in last-ball thriller to top IPL table
-
Israel's plan for Gaza draws international criticism
-
SpaceX gets US approval to launch more Starship flights from Texas
-
Alpine F1 team principal Oakes resigns
-
Colombia's desert north feels the pain of Trump's cuts
-
Arsenal determined 'to make a statement' against PSG in Champions League semi-final
-
Top US court allows Trump's ban on trans troops to take effect
-
Whole lotta legal argument: Led Zeppelin guitarist Page sued
-
US, Yemen's Huthis agree ceasefire: mediator Oman
-
Johnson receives special invite to PGA Championship
-
Trump says US should to stop 'subsidizing' Canada as trade talks continue
-
Indian PM vows to stop waters key to rival Pakistan
-
Thousands demonstrate in Panama over deal with US military
-
Canada 'never for sale', Carney tells Trump
-
Vatican readies for conclave lockdown
-
Championship club Watford sack manager Cleverley

Medicine Prize opens Nobel week clouded by war
Breast cancer discoveries and mRNA vaccines are seen as possible winners when the Nobel Medicine Prize kicks off a week of winner announcements on Monday, with this year's awards held under the shadow of war in Europe.
Established more than 120 years ago before Europe was ravaged by two world wars, the Nobel prizes will celebrate those who have "conferred the greatest benefit on mankind" after a year marked by bloodshed and devastation in Ukraine.
The Medicine Prize will be announced around 11:30 am (0930 GMT) in Stockholm on Monday, followed by the awards for physics on Tuesday, chemistry on Wednesday and literature on Thursday.
The Peace Prize, the most highly anticipated of the awards and the only one announced in Oslo, will follow on Friday, with the Economics Prize wrapping things up on October 10.
For medicine, one woman's name keeps popping up among prize watchers: US geneticist Mary-Claire King, who in 1990 discovered the BRCA1 gene responsible for a hereditary form of breast cancer.
She could be honoured together with oncologists Dennis Slamon of the United States and Germany's Axel Ullrich for their research, which led to the development of the breast cancer drug Herceptin.
However, if the jury were to break with its tradition of honouring decades-old research, another woman could be well placed for her role in fighting the Covid-19 pandemic.
- Male domination -
Already honoured by almost all other major medicine prizes, Hungarian-born Katalin Kariko could win for her pioneering research which led directly to the first mRNA vaccines to fight Covid-19, made by Pfizer and Moderna.
"There's not only the direct benefit that it gave us to fight the pandemic, it's also the first in a series of very promising applications using this technology," Nobel watcher Ulrika Bjorksten, the head of Swedish public radio's science service, told AFP.
Kariko could be honoured together with her collaborator Drew Weissman of the United States and Pieter Cullis of Canada.
Last year, the prize went to US researchers David Julius and Ardem Patapoutian for their discoveries on human receptors for temperature and touch.
David Pendlebury, who heads the closely watched Clarivate analytics group which lists dozens of possible winners for the Nobel science prizes, said his money was on King and Slamon this year.
But he also mentioned Hong Kong molecular biologist Yuk Ming Dennis Lo, who pioneered the development of non-invasive prenatal testing.
He also developed a new method of detecting cancer early using just a few drops of blood, dubbed liquid biopsies.
With a simple blood draw "you can determine all kinds of possible problems and diseases", Pendlebury said.
Male researchers based in the United States have overwhelmingly dominated the Nobel science prizes through the years.
The various prize committees have insisted they are trying to recognise women's achievements, but say many of the top discoveries were made decades ago when fewer women were involved in high-level research.
Last year, 12 men and one woman won Nobel Prizes, with all of the science nods going to men.
- Anti-Putin prizes? -
For the Literature Prize on Thursday, literary critics told AFP they thought the Swedish Academy may go for a more mainstream author this year, after selecting lesser-known writers the past two years.
Last year, Tanzanian author Abdulrazak Gurnah won, while US poet Louise Gluck was crowned in 2020.
US novelist Joyce Carol Oates, France's Annie Ernaux and Maryse Conde, Russia's Lyudmila Ulitskaya and Canada's Margaret Atwood have all been cited as potential laureates if the committee has its eyes on a woman.
Online betting sites however have France's Michel Houellebecq as the favourite, ahead of British author Salman Rushdie, who was the victim of an attempted murder attack in August.
But it is the Peace Prize that is expected to hold special significance this year.
After Russian journalist Dmitry Muratov won the prize last year together with his Philippine colleague Maria Ressa in the name of freedom of expression, will the Norwegian Nobel Committee award another anti-Putin prize after Moscow's invasion of Ukraine?
Not since World War II has a conflict raged between two countries so close to Oslo.
The International Criminal Court, tasked with investigating war crimes in Ukraine, and the International Court of Justice -- both based in The Hague -- have been mentioned as possible laureates this year.
So have jailed Russian dissident Alexei Navalny and Belarusian opposition leader Svetlana Tikhanovskaya.
If the committee were to focus on the climate crisis, experts tipped Swedish activist Greta Thunberg, possibly together with British environmentalist David Attenborough or other activists such as Sudan's Nisreen Elsaim and Ghana's Chibeze Ezekiel.
bur-map-aco-phy/po/imm
D.Sawyer--AMWN